News
Novo Nordisk's pipeline, especially the oral GLP-1 and Alzheimer’s trial, offers significant long-term upside. Click here to ...
Experts are warning anyone experiencing GLP-1 drug side effects to report them after launching an investigation into their safety.
LLY rides high on surging demand for Mounjaro and Zepbound, now nearly half its revenues ahead of Q2 earnings.
TOKYO-Nintendo's new Switch 2 videogame machine uses a rare-earth magnet to attach its hand-held controllers to the main console, according to a teardown, highlighting the company's vulnerability to ...
The drugmaker has become a clear winner with its weight-loss drugs. Now, with a pill under development, the company should ...
A 200% tariff rate — even with a delay — will have a detrimental effect on drug prices and profit margins, analysts warn.
AstraZeneca spinout Dizal Pharmaceuticals won an FDA accelerated approval for sunvozertinib for previously treated EGFR ex 20-mutated non-small cell lung cancer. To be marketed as Zegfrovy, the oral ...
Eli Lilly reported impressive data at the recent American Diabetes Association ('ADA') conference. Its robust pipeline will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results